Anika Therapeutics, Inc. (ANIK) Tops Q4 EPS by 3c
Get Alerts ANIK Hot Sheet
Price: $25.90 +0.43%
Revenue Growth %: +9.6%
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: +9.6%
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.51, $0.03 better than the analyst estimate of $0.48. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $24.6 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Teradyne (TER) Tops Q1 EPS by 18c
- First Bancshares (FBMS) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!